
  
    
      
        Background_NNP
        Prostate_NNP cancer_NN is_VBZ one_CD of_IN the_DT major_JJ diseases_NNS that_WDT pose_VBP
        serious_JJ health_NN problems_NNS for_IN aging_VBG men_NNS [_NN 1_CD ]_NN ._. It_PRP is_VBZ
        generally_RB believed_VBN that_DT androgen_NN has_VBZ a_DT significant_JJ role_NN in_IN
        the_DT development_NN and_CC progress_NN of_IN this_DT disease_NN [_NN 2_CD ]_NN ._.
        Changes_NNS in_IN the_DT growth_NN response_NN of_IN cancer_NN cells_NNS to_TO androgen_NN
        ablation_NN and_CC anti-androgen_JJ during_IN the_DT progress_NN of_IN the_DT
        disease_NN [_NN 3_CD 4_CD 5_CD 6_CD ]_NN suggest_VBP that_IN multiple_JJ androgen-related_JJ
        signaling_VBG events_NNS are_VBP involved_VBN in_IN neoplasia_NN and_CC disease_NN
        progression_NN ._. It_PRP has_VBZ also_RB been_VBN documented_VBN that_DT prostate_NN
        epithelial_NN cells_NNS exhibited_VBN squamous_JJ metaplastic_JJ phenotype_NN
        during_IN vitamin_NN A_DT deficiency_NN [_NN 7_CD ]_NN ,_, and_CC prostate_NN cell_NN
        carcinogenesis_NNS could_MD be_VB prevented_VBN by_IN retinoic_JJ acid_NN (_( RA_NNP )_) and_CC
        its_PRP$ analogs_NNS in_IN vitro_NN [_NN 8_CD 9_CD 10_CD ]_NN ._. These_DT findings_NNS suggest_VBP
        that_IN retinoid-dependent_JJ cellular_JJ events_NNS were_VBD involved_VBN in_IN
        tumorigenic_JJ transformation_NN of_IN prostate_NN epithelial_NN
        cells_NNS ._.
        Retinoic_NNP acid_NN receptors_NNS (_( RARs_NNP )_) and_CC retinoid_NN X_NNP receptors_NNS
        (_( RXRs_NNP )_) are_VBP nuclear_JJ transcription_NN factors_NNS that_WDT mediate_VB the_DT
        action_NN of_IN retinoids_NNS [_NN 11_CD 12_CD ]_NN ._. We_PRP have_VBP demonstrated_VBN that_IN
        in_IN the_DT rat_NN ,_, castration_NN resulted_VBD in_IN an_DT increase_NN in_IN mRNAs_NNS for_IN
        RAR_NNP α_NN and_CC γ_NN in_IN the_DT prostate_NN ;_: such_JJ effects_NNS were_VBD prevented_VBN by_IN
        T_NN replacement_NN [_NN 13_CD ]_NN ._. We_PRP also_RB demonstrated_VBD that_IN the_DT levels_NNS
        of_IN mRNAs_NNS for_IN RAR_NNP α_NN and_CC γ_NN in_IN non-tumorigenic_JJ rat_NN epithelial_NN
        cells_NNS (_( NRP_NNP 152_CD )_) were_VBD down-regulated_JJ ,_, whereas_IN those_DT in_IN
        tumorigenic_JJ cells_NNS (_( NRP_NNP 154_CD )_) were_VBD unaffected_JJ or_CC up-regulated_JJ
        following_NN T_NN treatment_NN [_NN 14_CD ]_NN ._. In_IN addition_NN ,_, RAR_NNP α_NN was_VBD
        over-expressed_JJ in_IN tumorigenic_JJ NRP_NNP 154_CD cells_NNS ._. These_DT findings_NNS
        suggest_VBP that_IN tumorigenic_JJ transformation_NN and_CC perhaps_RB
        neoplasia_NN of_IN prostate_NN epithelial_NN cells_NNS are_VBP associated_VBN with_IN
        abnormal_JJ expression_NN and_CC androgen_NN regulation_NN of_IN RARs_NNP ._.
        Androgen_NNP exerts_NNS its_PRP$ biologic_JJ effects_NNS by_IN binding_JJ to_TO and_CC
        activation_NN of_IN androgen_NN receptor_NN (_( AR_NNP )_) that_IN trans-activates_JJ
        target_NN genes_NNS through_IN androgen_NN responsive_JJ element_NN (_( ARE_VBP )_) in_IN
        the_DT promoter_NN of_IN target_NN genes_NNS [_NN 15_CD ]_NN ._. In_IN human_JJ breast_NN
        cancer_NN cells_NNS the_DT effectiveness_NN of_IN retinoids_NNS in_IN cell_NN growth_NN
        suppression_NN was_VBD dictated_VBN by_IN the_DT presence_NN of_IN RAR_NNP [_NN 16_CD ]_NN ._.
        Estrogen_NNP regulation_NN of_IN the_DT expression_NN of_IN RAR_NNP α_NN was_VBD mediated_JJ
        by_IN interactions_NNS between_IN estrogen_NN receptor_NN (_( ER_NNP )_) and_CC estrogen_NN
        responsive_JJ element_NN (_( ERE_NNP )_) in_IN the_DT promoter_NN of_IN RAR_NNP α_NN gene_NN [_NN 17_CD
        ]_NN ._. Because_IN the_DT DNA_NNP binding_JJ domains_NNS of_IN steroid_NN receptors_NNS
        including_VBG AR_NNP and_CC ER_NNP are_VBP highly_RB homologous_RB ,_, we_PRP postulated_JJ
        that_IN similar_JJ mechanisms_NNS might_MD also_RB mediate_VB the_DT effect_NN of_IN
        androgen_NN on_IN RAR_NNP genes_NNS in_IN prostate_NN cells_NNS ._.
        The_DT current_JJ experiments_NNS investigate_VB the_DT effects_NNS of_IN T_NN and_CC
        its_PRP$ interaction_NN with_IN RA_NNP on_IN cell_NN growth_NN and_CC the_DT expression_NN
        of_IN RARs_NNP in_IN human_JJ prostate_NN cancer_NN cells_NNS ,_, LNCaP_NNP ._. Furthermore_RB ,_,
        we_PRP present_JJ evidence_NN to_TO suggest_VB that_DT T_NN may_MD affect_VB the_DT
        expression_NN of_IN RAR_NNP α_NN gene_NN through_IN direct_JJ interaction_NN between_IN
        AR_NNP and_CC putative_JJ ARE_VBP in_IN the_DT promoter_NN of_IN RAR_NNP α_NN gene_NN ._. Because_IN
        EGF_NNP and_CC its_PRP$ receptor_NN (_( EGF-R_NNP )_) are_VBP involved_VBN in_IN prostate_NN cell_NN
        growth_NN ,_, and_CC their_PRP$ expression_NN can_MD be_VB modulated_JJ by_IN androgen_NN
        and_CC RA_NNP [_NN 18_CD 19_CD 20_CD ]_NN ,_, we_PRP also_RB examined_VBD the_DT interaction_NN of_IN T_NN
        and_CC RA_NNP on_IN the_DT expression_NN of_IN EGF-R_NNP ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Cell_NNP culture_NN
          Human_JJ prostate_NN carcinoma_NN cells_NNS ,_, LNCaP_NNP (_( ATCC_NNP ,_,
          Rockville_NNP ,_, MD_NNP )_) ,_, were_VBD maintained_VBN and_CC propagated_JJ in_IN T_NN 25_CD
          flasks_NNS in_IN RPMI_NNP 1640_CD media_NNS (_( GIBCO-BRL_NNP ,_, Gaithersburg_NNP ,_, MD_NNP )_)
          supplemented_JJ with_IN 10_CD %_NN FCS_NNP (_( Gemini_NNP Bio-_NNP Products_NNPS ,_,
          Calabasas_NNP ,_, CA_NNP )_) ,_, 2_CD mM_NN glutamine_NN ,_, Fungizone_NNP (_( 1_CD μg_NN /_NN ml_NN )_) and_CC
          penicillin_NN (_( 200_CD unit_NN /_NN ml_NN )_) /_NN streptomycin_NN (_( 200_CD μg_NN /_NN ml_NN )_)
          (_( referred_VBD as_IN complete_JJ medium_NN )_) in_IN a_DT 37_CD °_NN C_NNP humidified_JJ 5_CD %_NN CO_NNP 
          2_CD incubator_NN ._.
        
        
          3_LS H-_NNP thymidine_NN incorporation_NN
          Sub-confluent_NNP (_( 80_CD -_: 90_CD %_NN )_) LNCaP_NNP cells_NNS propagated_JJ in_IN T_NN 25_CD
          flasks_NNS were_VBD washed_VBN with_IN 5_CD ml_NN of_IN plain_JJ RPMI_NNP 1640_CD medium_NN
          and_CC trypsinized_JJ with_IN 5_CD ml_NN trypsin_NN /_NN EDTA_NNP solution_NN
          (_( GIBCO-BRL_NNP ,_, Gaithersburg_NNP ,_, MD_NNP )_) ._. The_DT cells_NNS were_VBD then_RB seeded_VBN
          onto_IN the_DT 12_CD -_: well_RB plates_NNS (_( 2_CD -_: 5_CD ×_NN 10_CD 4_CD cells_NNS /_NN well_RB )_) in_IN 4_CD ml_NN
          complete_JJ media_NNS ._. Two_CD days_NNS later_RB ,_, the_DT cells_NNS were_VBD well_RB
          attached_VBN and_CC covered_VBN 40_CD -_: 50_CD %_NN of_IN the_DT surface_NN area_NN ._. At_IN this_DT
          time_NN the_DT FCS_NNP in_IN the_DT medium_NN was_VBD replaced_VBN by_IN
          charcoal-stripped_JJ FCS_NNP (_( cFCS_NN ,_, Gemini_NNP Bio-_NNP Products_NNPS )_) ,_, and_CC
          various_JJ concentrations_NNS of_IN T_NN and_CC /_NN or_CC all_DT trans_NNS retinoic_JJ
          acid_NN (_( RA_NNP )_) were_VBD added_VBN in_IN triplicates_NNS ._. Three_CD days_NNS later_RB ,_,
          the_DT medium_NN was_VBD removed_VBN and_CC the_DT cells_NNS were_VBD incubated_JJ in_IN 1_CD
          ml_NN plain_JJ medium_NN containing_VBG 3_CD H-_NNP thymidine_NN (_( 0_CD ._. 5_LS μCi_NN /_NN ml_NN )_) for_IN
          an_DT additional_JJ 4_CD h_NN ._. After_IN washing_VBG twice_RB with_IN 3_CD ml_NN of_IN plain_JJ
          medium_NN ,_, the_DT cells_NNS were_VBD lysed_JJ with_IN 0_CD ._. 2_CD ml_NN of_IN lysis_NNS buffer_NN
          containing_VBG 0_CD ._. 1_CD M_NNP NaCl_NNP ,_, 0_CD ._. 01_CD M_NNP EDTA_NNP ,_, 0_CD ._. 3_CD M_NNP Tris-_NNP HCl_NNP (_( pH_NN
          8_CD ._. 0_CD )_) ,_, 0_CD ._. 2_CD M_NNP sucrose_NN and_CC 0_CD ._. 5_CD %_NN SDS_NNP ._. DNA_NNP was_VBD extracted_VBN with_IN
          phenol_NN /_NN chloroform_NN /_NN isoamyl_NN alcohol_NN (_( 25_CD :_: 24_CD :_: 1_LS )_) solution_NN and_CC
          precipitated_VBD with_IN an_DT equal_JJ volume_NN of_IN isopropanol_NN ._. After_IN
          washing_VBG with_IN 70_CD %_NN ethanol_NN ,_, DNA_NNP was_VBD subsequently_RB
          precipitated_VBD by_IN centrifugation_NN ._. The_DT specific_JJ activity_NN of_IN
          3_CD H-_NNP thymidine_NN was_VBD then_RB determined_VBN and_CC expressed_VBN as_IN cpm_NN /_NN μg_NN
          DNA_NNP ._.
        
        
          Northern_JJ blot_NN analysis_NN of_IN RAR_NNP mRNA_NN
          To_TO determine_VB the_DT effects_NNS of_IN T_NN on_IN RAR_NNP mRNA_NN expression_NN ,_,
          LNCaP_NNP cells_NNS were_VBD propagated_JJ in_IN 20_CD ml_NN complete_JJ medium_NN in_IN
          T_NN 175_CD flasks_NNS ,_, with_IN medium_NN change_NN every_DT 4_CD th_NN day_NN ,_, until_IN the_DT
          monolayers_NNS reached_VBD >_NN 90_CD %_NN confluence_NN (_( usually_RB 8_CD -_: 10_CD days_NNS
          after_IN seeding_VBG )_) ._. The_DT FCS_NNP in_IN the_DT medium_NN was_VBD then_RB replaced_VBN
          by_IN cFCS_NN ._. 48_CD h_NN later_RB ,_, various_JJ concentrations_NNS of_IN testerone_NN
          were_VBD added_VBN in_IN the_DT absence_NN or_CC presence_NN of_IN 100_CD nM_NN RA_NNP ._. The_DT
          cells_NNS were_VBD harvested_VBN 6_CD h_NN later_RB ._. This_DT time_NN was_VBD selected_VBN
          based_VBN on_IN results_NNS of_IN preliminary_JJ experiments_NNS (_( data_NNS not_RB
          shown_VBN )_) ._.
          Detailed_NNP procedures_NNS for_IN isolation_NN of_IN total_JJ RNA_NNP ,_,
          enrichment_NN of_IN poly_RB (_( A_DT )_) +_NN RNA_NNP by_IN oligo-d_JJ T_NN cellulose_NN
          chromatography_NN and_CC electrophoresis_NNS and_CC Northern_NNP blotting_VBG
          of_IN RNA_NNP have_VBP been_VBN described_VBN previously_RB [_NN 13_CD ]_NN ._. The_DT cDNA_NN
          probes_NNS of_IN mouse_NN RAR_NNP α_NN and_CC RAR_NNP γ_NN [_NN 21_CD 22_CD ]_NN were_VBD isolated_VBN
          by_IN agarose_NN electrophoresis_NNS after_IN appropriate_JJ
          endonucleases_NNS digestion_NN and_CC were_VBD radio-labeled_JJ with_IN
          32_CD P-_NNP dCTP_NN ,_, using_VBG random_JJ priming_VBG kit_NN (_( Boehringer-_NNP Mannheim_NNP ,_,
          Indianapolis_NNP ,_, IN_IN )_) ._. The_DT blots_NNS were_VBD pre-hybridized_JJ in_IN a_DT
          solution_NN containing_VBG 6_CD -_: strength_NN SSC_NNP (_( 150_CD mM_NN NaCl_NNP ,_, 15_CD mM_NN
          Na-citrate_NNP ,_, pH_NN 7_CD ._. 0_CD )_) ,_, 0_CD ._. 5_CD %_NN SDS_NNP ,_, 50_CD %_NN formamide_NN ,_, and_CC 100_CD
          mg_NN /_NN ml_NN denatured_JJ sperm_NN DNA_NNP at_IN 42_CD °_NN C_NNP for_IN 2_CD -_: 4_CD h_NN ,_, and_CC were_VBD
          hybridized_JJ overnight_JJ in_IN the_DT same_JJ buffer_NN containing_VBG
          approximately_RB 10_CD 6_CD cpm_NN /_NN ml_NN of_IN radiolabeled_JJ cDNA_NN probe_NN ._. The_DT
          membranes_NNS were_VBD washed_VBN in_IN 1_CD ×_NN SSC_NNP solution_NN containing_VBG 0_CD ._. 1_CD %_NN
          SDS_NNP at_IN 68_CD °_NN C_NNP for_IN 20_CD -_: 30_CD min_NN ,_, followed_VBN by_IN several_JJ changes_NNS in_IN
          0_CD ._. 2_CD -_: strength_NN SSC_NNP and_CC 0_CD ._. 1_CD %_NN SDS_NNP at_IN 68_CD °_NN C_NNP for_IN 2_CD -_: 4_CD h_NN ._. The_DT
          radioautographs_NNS were_VBD developed_VBN after_IN they_PRP were_VBD exposes_NNS to_TO
          Kodak_NNP (_( Eastman_NNP Kodak_NNP ,_, Rochster_NNP ,_, NY_NNP )_) XAR-_NNP 5_CD film_NN for_IN 2_CD -_: 10_CD
          days_NNS using_VBG an_DT intensifying_VBG screen_NN ._. The_DT membranes_NNS were_VBD
          subsequently_RB stripped_VBN and_CC rehybridized_JJ with_IN 32_CD P_NN labeled_VBD
          cDNA_NN for_IN 18_CD S_NNP ribosomal_JJ RNA_NNP ._. The_DT relative_JJ abundance_NN of_IN
          different_JJ transcripts_NNS (_( RAR_NNP α_NN ,_, 3_CD ._. 4_CD and_CC 2_CD ._. 7_CD Kb_NNP ;_: RAR_NNP γ_NN ,_, 3_CD ._. 4_CD
          Kb_NNP )_) were_VBD scanned_JJ ,_, and_CC area_NN under_IN the_DT curve_NN was_VBD estimated_VBN
          by_IN densitometry_NN ._. The_DT result_NN of_IN each_DT sample_NN was_VBD normalized_JJ
          against_IN that_DT of_IN the_DT 18_CD S_NNP ribosomal_JJ RNA_NNP in_IN each_DT sample_NN ._. The_DT
          average_JJ ratio_NN between_IN the_DT mRNA_NN and_CC the_DT 18_CD S_NNP ribosomal_JJ RNA_NNP
          of_IN untreated_JJ control_NN cells_NNS were_VBD considered_VBN 100_CD %_NN ,_, and_CC the_DT
          results_NNS for_IN individual_JJ experimental_JJ samples_NNS in_IN each_DT blot_NN
          were_VBD expressed_VBN as_IN a_DT percentage_NN of_IN this_DT average_NN ._.
        
        
          Electrophoretic_NNP mobility_NN shift_NN assays_NNS (_( EMSA_NNP )_)
          The_DT oligo_NN corresponding_JJ to_TO nucleotides_NNS -_: 100_CD to_TO -_: 59_CD of_IN
          RAR_NNP α_NN promoter_NN (_( antisense_NN strand_NN :_: 5_CD '_POS
          TCGACTGCCCGCCCACCGACCAATCACCAGTCAGGGGCGGATCTAC_NNP 3_CD '_POS ;_: sense_NN
          strand_NN :_: 5_CD '_POS CCGGGTAGATCCGCCCCTGACTGGTGATTGGTCGGTGGGCGGGCAG_NNP
          3_CD '_POS )_) [_NN 17_CD ]_NN was_VBD synthesized_JJ by_IN the_DT New_NNP Jersey_NNP Medical_NNP
          School_NNP Molecular_NNP Resource_NNP Facility_NNP ._. The_DT oligo_NN probes_NNS were_VBD
          radiolabeled_JJ using_VBG the_DT Klenow_NNP fragment_NN of_IN DNA_NNP polymerase_NN
          and_CC 32_CD P-_NNP dATP_NN ._. The_DT binding_JJ between_IN DNA_NNP and_CC AR_NNP was_VBD
          determined_VBN by_IN gel_NN electrophoretic_JJ mobility_NN shift_NN assay_NN ._.
          Purified_NNP human_JJ AR_NNP protein_NN over-expressed_JJ in_IN the_DT
          baculovirus_JJ [_NN 23_CD ]_NN or_CC nuclear_JJ protein_NN extracts_NNS of_IN LNCaP_NNP
          cells_NNS were_VBD incubated_JJ with_IN 2_CD μg_NN
          polydeoxynosinic-deoxycytidylic_JJ acid_NN and_CC 1_CD ×_NN binding_JJ
          buffer_NN (_( 10_CD mM_NN HEPES_NNP ,_, pH_NN 7_CD ._. 5_CD ,_, 1_CD mM_NN mercaptoethanol_NN ,_, 10_CD %_NN
          glycerol_NN and_CC 50_CD mM_NN KCl_NNP )_) on_IN ice_NN for_IN 30_CD -_: 60_CD min_NN ._. After_IN
          addition_NN of_IN 32_CD P-_NNP labeled_VBD probe_NN (_( 1_CD ng_NN /_NN reaction_NN )_) ,_, the_DT
          mixture_NN was_VBD incubated_JJ for_IN an_DT additional_JJ 30_CD min_NN on_IN ice_NN ._.
          Non-specific_NNP competitor_NN (_( 5_CD '_POS CGCCC_NNP GGGGT_NNP CCTCA_NNP GCG_NNP 3_CD '_POS )_) or_CC
          excess_JJ unlabeled_JJ specific_JJ probe_NN were_VBD added_VBN 10_CD -_: 15_CD min_NN
          before_IN adding_VBG the_DT radioactive_JJ probe_NN ._. To_TO super-shift_JJ the_DT
          AR-DNA_NNP complex_NN ,_, AR_NNP protein_NN was_VBD incubated_JJ with_IN polyclonal_NN
          AR-specific_NNP antibody_NN (_( CW_NNP 2_LS )_) [_NN 24_CD ]_NN prior_RB to_TO the_DT addition_NN
          of_IN the_DT radioactive_JJ oligo_NN probe_NN ._. The_DT reaction_NN mixtures_NNS
          were_VBD electrophoresed_JJ on_IN a_DT 6_CD %_NN non-denaturing_JJ
          polyacrylamide_NN gel_NN (_( acrylamide_NN :_: bisacrylamide_NN ,_, 30_CD :_: 0_CD ._. 8_CD )_)
          containing_VBG 5_CD %_NN glycerol_NN at_IN 180_CD V_NNP in_IN TAE_NNP buffer_NN (_( 1_CD mM_NN
          DEAE_NNP ,_, 3_CD ._. 3_CD mM_NN sodium_NN acetate_NN and_CC 6_CD ._. 7_CD mM_NN Tris_NNP ,_, pH_NN 7_CD ._. 5_LS )_) ._. The_DT
          gels_NNS were_VBD dried_VBN at_IN 60_CD °_NN C_NNP and_CC DNA_NNP /_NN protein_NN binding_JJ was_VBD
          visualized_JJ by_IN radioautography_NN ._. The_DT same_JJ experiments_NNS were_VBD
          repeated_VBN at_IN least_JJS 3_CD times_NNS ._.
        
        
          Measurement_NNP of_IN EGF_NNP receptor_NN
          
            Ligand-binding_NNP assay_NN
            Duplicates_NNP of_IN membrane_NN preparations_NNS equivalent_JJ to_TO
            0_CD ._. 1_CD mg_NN protein_NN were_VBD incubated_JJ with_IN 125_CD I-EGF_NNP (_( 50_CD or_CC 100_CD
            ng_NN ;_: Amersham_NNP Life_NNP Sciences_NNPS ,_, Arlington_NNP Heights_NNP ,_, IL_NNP )_) in_IN
            200_CD μl_NN reaction_NN buffer_NN (_( 5_CD mM_NN Tris-_NNP HCl_NNP ,_, pH_NN 7_CD ._. 0_CD ,_, 125_CD mM_NN
            sucrose_NN ,_, 75_CD mM_NN NaCl_NNP ,_, 0_CD ._. 5_CD mM_NN Ca_MD 2_CD +_NN and_CC 0_CD ._. 5_CD %_NN BSA_NNP )_) at_IN 25_CD °_NN C_NNP
            for_IN 60_CD min_NN ._. Non-specific_NNP binding_JJ was_VBD obtained_VBN by_IN adding_VBG
            100_CD ×_NN non-radioactive_JJ EGF_NNP (_( Sigma_NNP Biochemicals_NNP ,_, St_NNP ._.
            Louis_NNP ,_, MO_NNP )_) ._. The_DT reaction_NN was_VBD stopped_VBN by_IN addition_NN of_IN 1_CD
            ml_NN ice_NN cold_JJ washing_NN buffer_NN (_( 5_CD mM_NN Tris-_NNP HCl_NNP and_CC 0_CD ._. 5_CD %_NN BSA_NNP ,_,
            pH_NN 7_CD ._. 0_CD )_) ,_, and_CC membrane_NN bound_VBN (_( 125_CD I_PRP )_) EGF_NNP was_VBD precipitated_VBD
            immediately_RB by_IN centrifugation_NN (_( 14_CD ,_, 000_CD rpm_NN ×_NN 4_CD min_NN )_) at_IN
            4_CD °_NN C_NNP ._. The_DT pellets_NNS were_VBD washed_VBN with_IN 1_CD ml_NN washing_VBG buffer_NN
            and_CC re-pelleted_JJ ._. Specific_JJ binding_JJ was_VBD obtained_VBN by_IN
            subtracting_VBG non-specific_JJ binding_JJ (_( in_IN the_DT presence_NN of_IN a_DT
            100_CD -_: fold_VB excess_JJ unlabeled_JJ EGF_NNP )_) from_IN total_JJ binding_JJ ._. The_DT
            results_NNS were_VBD expressed_VBN as_IN fmol_NN /_NN mg_NN protein_NN ._.
          
          
            Western_JJ blots_NNS analysis_NN of_IN EGF-R_NNP
            The_DT cell_NN pellets_NNS were_VBD re-suspended_JJ in_IN 1_CD ml_NN PBS_NNP ,_,
            lysed_JJ by_IN boiling_VBG and_CC stored_VBD as_IN 0_CD ._. 1_CD ml_NN aliquots_NNS at_IN
            -_: 70_CD °_NN C_NNP ._. For_IN Western_JJ blot_NN analysis_NN ,_, 15_CD μl_NN of_IN samples_NNS
            containing_VBG 20_CD μg_NN protein_NN were_VBD mixed_VBN with_IN equal_JJ volume_NN
            of_IN 2_CD ×_NN loading_NN buffer_NN (_( 1_CD X_NNP =_SYM 125_CD mM_NN TRIS-HCl_NNP ,_, pH_NN 6_CD ._. 8_CD ;_: 2_CD %_NN
            SDS_NNP ,_, 5_CD %_NN glycerol_NN ,_, 0_CD ._. 003_CD %_NN bromphenol_NN blue_JJ and_CC 1_CD %_NN
            1_CD -_: mercaptoethanol_NN )_) ,_, and_CC boiled_VBD for_IN 5_CD min_NN ._. Fifteen_CD (_( 15_CD )_)
            μl_NN of_IN the_DT samples_NNS were_VBD electrophoresed_JJ on_IN a_DT 7_CD ._. 5_CD %_NN
            SDS-polyacrylamide_NNP mini-gel_JJ for_IN 1_CD h_NN at_IN 150_CD V_NNP ._. The_DT
            proteins_NNS were_VBD transferred_VBN to_TO a_DT PVDF_NNP membrane_NN (_( Amersham_NNP
            Life_NNP Sciences_NNPS ,_, Arlington_NNP Heights_NNP ,_, IL_NNP )_) using_VBG a_DT Mini_NNP
            Trans-blot_NNP Cell_NNP (_( Bio_NNP Rad_NNP Laboratories_NNPS ,_, Hercules_NNP ,_, CA_NNP )_) at_IN
            50_CD mA_NN ._. The_DT membranes_NNS were_VBD blocked_VBN overnight_JJ at_IN 4_CD °_NN C_NNP in_IN
            TBST_NNP (_( 10_CD mM_NN Tris-_NNP HCl_NNP ,_, 150_CD mM_NN NaCl_NNP ,_, 0_CD ._. 05_CD %_NN Tween_NNP ;_: pH_NN 8_CD ._. 0_CD )_)
            containing_VBG 3_CD %_NN fat_JJ free_JJ dry_JJ milk_NN ._. Thereafter_RB ,_, the_DT
            membrane_NN was_VBD incubated_JJ with_IN a_DT monoclonal_NN anti-human_JJ
            EGF-R_NNP antibody_NN (_( Oncogene_NNP Research_NNP Products_NNPS ,_, Cambridge_NNP ,_,
            MA_NNP )_) diluted_VBN 1_CD :_: 10_CD in_IN TBST_NNP at_IN room_NN temperature_NN for_IN 2_CD h_NN ._.
            After_IN washing_VBG in_IN TBST_NNP for_IN 1_CD h_NN ,_, the_DT membrane_NN was_VBD
            incubated_JJ with_IN anti_NN mouse_NN IgG_NNP /_NN peroxidase_NN conjugate_NN
            (_( 1_CD :_: 8_CD ,_, 000_CD in_IN TBST_NNP )_) for_IN 1_CD h_NN at_IN room_NN temperature_NN ._. The_DT
            signal_NN was_VBD enhanced_VBN by_IN ECL_NNP Western_JJ blot_NN detection_NN kit_NN
            (_( Amersham_NNP Life_NNP Sciences_NNPS ,_, Arlington_NNP Heights_NNP ,_, IL_NNP )_) and_CC
            exposed_VBN to_TO Kodak_NNP X-OMAT_NNP film_NN ._. The_DT identical_JJ experiments_NNS
            were_VBD repeated_VBN 3_CD times_NNS ._.
          
        
        
          Statistics_NNS
          Analysis_NNP of_IN variance_NN (_( ANOVA_NNP )_) was_VBD used_VBN to_TO detect_VB the_DT
          dose-effect_JJ of_IN T_NN and_CC /_NN or_CC RA_NNP ,_, using_VBG the_DT JMP_NNP statistical_JJ
          software_NN package_NN (_( SAS_NNP Institute_NNP ,_, Cary_NNP ,_, NC_NNP )_) ._. Subsequently_RB ,_,
          Dunnetts_NNP multiple-range_JJ test_NN was_VBD used_VBN to_TO compare_VB the_DT
          means_NNS among_IN groups_NNS ._. Unpaired_NNP Student_NNP 's_POS t_NN test_NN was_VBD used_VBN to_TO
          determine_VB the_DT effect_NN of_IN RA_NNP on_IN the_DT RAR_NNP mRNA_NN responses_NNS to_TO
          T_NN ._.
        
      
      
        Results_NNS
        
          3_LS H-_NNP thymidine_NN incorporation_NN
          Treatment_NNP of_IN LNCaP_NNP cells_NNS with_IN 0_CD ._. 02_CD -_: 2000_CD nM_NN T_NN alone_RB for_IN
          3_CD days_NNS resulted_VBD in_IN dose-dependent_JJ ,_, biphasic_JJ stimulation_NN
          of_IN 3_CD H-_NNP thymidine_NN incorporation_NN (_( p_NN <_NN 0_CD ._. 05_CD ;_: Figure_NN 1_CD A_DT )_) ._.
          While_IN effects_NNS of_IN 0_CD ._. 02_CD nM_NN T_NN was_VBD abolished_VBN by_IN 1_CD and_CC 100_CD nM_NN
          RA_NNP (_( p_NN <_NN 0_CD ._. 05_CD )_) ,_, the_DT effect_NN of_IN higher_JJR doses_NNS of_IN T_NN were_VBD
          suppressed_VBN by_IN all_DT doses_NNS of_IN RA_NNP used_VBD (_( p_NN <_NN 0_CD ._. 05_CD )_) ._. The_DT
          extent_NN of_IN suppression_NN depended_VBD on_IN the_DT doses_NNS of_IN both_DT T_NN and_CC
          RA_NNP ._. Specifically_RB ,_, 3_CD H-_NNP thymidine_NN uptake_NN in_IN cells_NNS treated_VBN
          with_IN 20_CD -_: 2000_CD nM_NN T_NN was_VBD suppressed_VBN by_IN the_DT presence_NN of_IN 1_CD nM_NN
          RA_NNP to_TO an_DT extent_NN that_WDT was_VBD significantly_RB lower_JJR than_IN
          untreated_JJ controls_NNS (_( p_NN <_NN 0_CD ._. 05_CD )_) ._. Similarly_RB ,_, treatment_NN of_IN
          LNCaP_NNP cells_NNS with_IN 0_CD ._. 01_CD -_: 10_CD nM_NN RA_NNP alone_RB resulted_VBD in_IN 50_CD -_: 70_CD %_NN
          stimulation_NN of_IN 3_CD H-_NNP thymidine_NN uptake_NN (_( p_NN <_NN 0_CD ._. 05_CD ,_, Figure_NN
          1_CD B_NNP )_) ;_: these_DT effects_NNS were_VBD suppressed_VBN by_IN concomitant_NN
          presence_NN of_IN 0_CD ._. 02_CD -_: 200_CD nM_NN T_NN (_( p_NN <_NN 0_CD ._. 05_CD )_) ._. Such_JJ effects_NNS
          became_VBD less_RBR pronounced_JJ when_WRB higher_JJR doses_NNS of_IN RA_NNP were_VBD used_VBN ._.
          Combination_NNP of_IN 100_CD and_CC 1000_CD nM_NN RA_NNP with_IN 0_CD ._. 02_CD nM_NN T_NN resulted_VBD
          in_IN lower_JJR 3_CD H-_NNP thymidine_NN uptake_NN than_IN those_DT cells_NNS treated_VBN
          with_IN RA_NNP alone_RB (_( p_NN <_NN 0_CD ._. 05_CD )_) ._.
        
        
          RAR_NNP α_NN and_CC γ_NN mRNA_NN
          Treatment_NNP of_IN LNCaP_NNP cells_NNS with_IN T_NN alone_RB for_IN 6_CD h_NN resulted_VBD
          in_IN dose-dependent_JJ ,_, biphasic_JJ increases_NNS in_IN levels_NNS of_IN RAR_NNP α_NN
          and_CC γ_NN mRNA_NN transcripts_NNS ,_, with_IN the_DT maximal_NN effect_NN of_IN 2_CD -_: 20_CD
          nM_NN (_( P_NN <_NN 0_CD ._. 05_CD ;_: Figure_NN 2_LS )_) ._. When_WRB the_DT cells_NNS were_VBD treated_VBN
          with_IN T_NN in_IN the_DT presence_NN of_IN 100_CD nM_NN RA_NNP ,_, the_DT RAR_NNP α_NN and_CC γ_NN
          mRNAs_NNS in_IN LNCaP_NNP cells_NNS were_VBD suppressed_VBN in_IN a_DT dose_NN dependent_JJ
          manner_NN (_( P_NN <_NN 0_CD ._. 05_CD ,_, Figure_NN 3_LS )_) ._. The_DT 4_CD ._. 0_CD kb_NN RAR_NNP α_NN mRNA_NN was_VBD
          not_RB affected_VBN by_IN these_DT treatments_NNS ._.
        
        
          Electrophoretic_NNP mobility_NN shift_NN assay_NN (_( EMSA_NNP )_)
          Incubation_NNP of_IN AR_NNP protein_NN with_IN the_DT 32_CD P-_NNP labeled_VBD oligo_NN
          probe_NN of_IN RAR_NNP α_NN promoter_NN resulted_VBD in_IN a_DT protein-_NN DNA_NNP complex_JJ
          after_IN EMSA_NNP (_( Figure_NN 4_CD A_DT )_) ;_: radioactivity_NN of_IN the_DT complex_NN was_VBD
          displaced_VBN by_IN unlabeled_JJ oligo_NN probe_NN ,_, but_CC not_RB by_IN oligo_NN
          probe_NN of_IN unrelated_JJ sequences_NNS ._. This_DT complex_NN was_VBD not_RB
          present_JJ when_WRB the_DT probe_NN was_VBD incubated_JJ with_IN BSA_NNP ._. Incubation_NNP
          of_IN nuclear_JJ extracts_NNS of_IN LNCaP_NNP cells_NNS with_IN the_DT 32_CD P-_NNP oligo_NN
          probe_NN also_RB resulted_VBD in_IN a_DT complex_NN that_IN migrated_JJ to_TO the_DT
          same_JJ distance_NN as_IN that_DT achieved_VBN by_IN AR-_NNP 32_CD P-_NNP oligo_NN probe_NN
          complex_JJ (_( Figure_NN 4_CD B_NNP )_) ._. The_DT specificity_NN of_IN such_JJ complex_NN was_VBD
          demonstrated_VBN by_IN displacement_NN of_IN radioactivity_NN with_IN
          unlabeled_JJ specific_JJ oligo_NN probe_NN ._. Incubation_NNP of_IN AR_NNP protein_NN
          with_IN anti-_NN AR_NNP polyclonal_NN antibody_NN (_( CW_NNP 2_LS )_) prior_RB to_TO the_DT
          addition_NN of_IN 32_CD P-_NNP labeled_VBD oligo_NN probe_NN resulted_VBD in_IN
          super-shifting_JJ of_IN the_DT protein-_NN DNA_NNP complex_JJ (_( Figure_NN
          4_CD C_NNP )_) ._.
        
        
          Interaction_NNP of_IN RA_NNP and_CC T_NN on_IN EGF-R_NNP
          Figure_NN 5_CD shows_VBZ that_DT treatment_NN of_IN LNCaP_NNP cells_NNS with_IN RA_NNP
          (_( 100_CD nM_NN )_) alone_RB for_IN 24_CD h_NN resulted_VBD in_IN >_NN 20_CD %_NN decrease_NN in_IN
          the_DT binding_JJ of_IN 125_CD I-EGF_NNP and_CC membrane_NN proteins_NNS (_( P_NN <_NN
          0_CD ._. 05_CD )_) ._. On_IN the_DT other_JJ hand_NN ,_, binding_JJ of_IN 125_CD I-EGF_NNP was_VBD
          stimulated_VBN by_IN 75_CD %_NN in_IN cells_NNS treated_VBN with_IN 20_CD nM_NN T_NN (_( P_NN <_NN
          0_CD ._. 05_CD )_) ,_, but_CC this_DT effect_NN was_VBD attenuated_JJ by_IN the_DT presence_NN of_IN
          RA_NNP ._. Western_JJ blot_NN analysis_NN revealed_VBD a_DT similar_JJ pattern_NN of_IN
          change_NN in_IN the_DT 170_CD kd_NN EGF-R_NNP protein_NN ._.
        
      
      
        Discussion_NNP
        Androgen_NNP is_VBZ essential_JJ for_IN normal_JJ prostate_NN function_NN ,_, but_CC
        has_VBZ also_RB been_VBN implicated_VBN in_IN the_DT pathogenesis_NNS and_CC neoplasia_NN
        of_IN prostate_NN cancer_NN [_NN 1_CD 2_CD 26_CD ]_NN ._. On_IN the_DT other_JJ hand_NN ,_, retinoid_NN
        is_VBZ essential_JJ for_IN normal_JJ prostate_NN function_NN [_NN 7_CD 27_CD 28_CD ]_NN and_CC
        exhibits_VBZ anti-proliferative_JJ and_CC chemopreventive_JJ efficacy_NN in_IN
        experimental_JJ prostate_NN carcinoma_NN [_NN 8_CD 9_CD 10_CD ]_NN ._. The_DT
        dose-dependent_JJ stimulation_NN of_IN 3_CD H-_NNP thymidine_NN incorporation_NN in_IN
        LNCaP_NNP cells_NNS by_IN T_NN and_CC RA_NNP when_WRB administered_VBN alone_RB ,_, and_CC
        reciprocal_JJ suppression_NN of_IN such_JJ effects_NNS by_IN each_DT other_JJ ,_, are_VBP
        consistent_JJ with_IN previous_JJ findings_NNS [_NN 29_CD 30_CD 31_CD 32_CD ]_NN ._. These_DT
        results_NNS illustrate_VBP interactions_NNS between_IN androgen_NN and_CC
        retinoid_NN in_IN the_DT control_NN of_IN LNCaP_NNP cell_NN growth_NN ._. A_DT correlation_NN
        between_IN dose_NN effect_NN of_IN T_NN on_IN 3_CD H-_NNP thymidine_NN incorporation_NN and_CC
        that_IN on_IN RAR_NNP α_NN and_CC γ_NN mRNA_NN levels_NNS further_JJ suggests_VBZ that_IN RAR_NNP
        signaling_VBG events_NNS might_MD be_VB involved_VBN in_IN such_JJ interaction_NN ._.
        Stimulation_NNP of_IN LNCaP_NNP cell_NN growth_NN by_IN RAR_NNP analog_NN [_NN 33_CD ]_NN and_CC
        over-expression_JJ of_IN RAR_NNP α_NN in_IN tumorigenic_JJ rat_NN prostate_NN
        epithelial_NN cells_NNS [_NN 14_CD ]_NN support_NN the_DT above_JJ notion_NN ._.
        Modulation_NNP of_IN the_DT expression_NN of_IN EGF_NNP and_CC its_PRP$ receptor_NN
        (_( EGF-R_NNP )_) in_IN prostate_NN cells_NNS by_IN androgen_NN [_NN 18_CD 19_CD 26_CD ]_NN ,_, and_CC
        over-expression_JJ of_IN EGF-R_NNP during_IN the_DT advanced_VBN stages_NNS of_IN
        prostate_NN cancer_NN [_NN 34_CD ]_NN ,_, imply_VBP that_IN EGF_NNP /_NN EGF-R_NNP signaling_VBG
        events_NNS might_MD be_VB involved_VBN in_IN neoplasia_NN and_CC perhaps_RB
        progression_NN of_IN prostate_NN cancer_NN ._. An_DT increase_NN in_IN EGF-R_NNP in_IN
        LNCaP_NNP cells_NNS after_IN treatment_NN with_IN growth-stimulating_JJ dose_NN of_IN
        T_NN is_VBZ consistent_JJ with_IN this_DT postulate_NN ._. Suppression_NN of_IN EGF-R_NNP
        in_IN LNCaP_NNP cells_NNS after_IN treatment_NN with_IN a_DT dose_NN of_IN RA_NNP that_IN also_RB
        attenuated_JJ the_DT stimulating_VBG effect_NN of_IN T_NN on_IN EGF-R_NNP ,_, further_JJ
        suggest_VBP that_IN EGF-R_NNP signaling_VBG might_MD have_VB a_DT role_NN in_IN the_DT
        interaction_NN between_IN T_NN and_CC RA_NNP on_IN LNCaP_NNP cell_NN growth_NN ._. In_IN this_DT
        regard_NN ,_, RA_NNP was_VBD reported_VBN to_TO blunt_VB the_DT growth_NN response_NN of_IN
        LNCaP_NNP cells_NNS to_TO EGF_NNP [_NN 31_CD ]_NN ._. These_DT investigators_NNS also_RB
        reported_VBD increases_NNS and_CC decreases_NNS in_IN LNCaP_NNP cells_NNS in_IN S-_NNP phase_NN
        after_IN exposure_NN to_TO growth_VB stimulating_VBG and_CC anti-proliferative_JJ
        doses_NNS of_IN RA_NNP ,_, respectively_RB ._. Treatment_NNP of_IN LNCaP_NNP cells_NNS with_IN an_DT
        RXR_NNP agonist_NN also_RB caused_VBD an_DT increase_NN in_IN G_NNP 1_CD cells_NNS and_CC a_DT
        decrease_NN in_IN S_NNP phase_NN cells_NNS [_NN 33_CD ]_NN ,_, suggesting_VBG that_DT cell_NN
        cycle_NN kinetics_NNS are_VBP involved_VBN in_IN the_DT effects_NNS of_IN RA_NNP /_NN RAR_NNP
        signaling_VBG ._.
        Binding_NNP between_IN AR_NNP and_CC nucleotide_NN sequences_NNS of_IN the_DT
        promoter_NN of_IN the_DT RAR_NNP α_NN gene_NN and_CC that_IN such_JJ protein-_NN DNA_NNP
        complex_NN was_VBD super-shifted_JJ in_IN the_DT presence_NN of_IN anti-_NN AR_NNP serum_NN
        suggest_VBP the_DT presence_NN of_IN ARE_VBP in_IN RAR_NNP α_NN gene_NN ._. This_DT notion_NN is_VBZ
        supported_VBN by_IN the_DT presence_NN ,_, within_IN the_DT oligo_NN probe_NN ,_, of_IN
        nucleotides_NNS sequences_NNS 5_CD '_POS AGATCC_NNP 3_CD '_POS 
        (_( n-_NN 98_CD to_TO -_: 93_CD )_) and_CC 5_CD '_POS ACTGGT_NNP 3_CD '_POS 
        (_( n-_NN 85_CD to_TO -_: 80_CD )_) which_WDT are_VBP identical_JJ or_CC
        complementary_JJ to_TO half_NN of_IN the_DT palindromic_JJ ARE_VBP motif_NN of_IN
        prostatien_NN C_NNP 3_CD subunit_NN gene_NN (_( 5_CD '_POS AGTACG_NNP 3_CD '_POS )_) [_NN 35_CD ]_NN and_CC that_IN of_IN
        PSA_NNP promoter_NN (_( 5_CD '_POS AGTGCT_NNP 3_CD '_POS )_) [_NN 20_CD ]_NN ,_, respectively_RB ._. Binding_NNP
        between_IN LNCaP_NNP cell_NN nuclear_JJ extract_NN and_CC oligo_NN probe_NN of_IN RAR_NNP α_NN
        promoter_NN thus_RB suggests_VBZ that_IN AR-ARE_NNP interaction_NN might_MD
        mediate_VB the_DT effects_NNS of_IN T_NN on_IN the_DT expression_NN of_IN RAR_NNP α_NN in_IN
        LNCaP_NNP cells_NNS ._. A_DT similar_JJ mechanism_NN may_MD also_RB pertain_NN for_IN the_DT
        effects_NNS of_IN T_NN on_IN RAR_NNP γ_NN since_IN the_DT DNA_NNP binding_JJ domains_NNS are_VBP
        highly_RB homologous_RB among_IN RARs_NNP ._. In_IN addition_NN ,_, sequences_NNS in_IN
        other_JJ segments_NNS of_IN the_DT RAR_NNP α_NN promoter_NN including_VBG 5_CD '_POS GGGACA_NNP 3_CD '_''
        
        (_( n_NN -_: 46_CD to_TO -_: 41_CD )_) and_CC 5_CD '_POS TCTGCT_NNP 3_CD '_POS 
        (_( n_NN -_: 25_CD to_TO -_: 20_CD )_) were_VBD similar_JJ or_CC
        complementary_JJ to_TO that_DT of_IN half_JJ site_NN of_IN the_DT up-stream_JJ ARE_VBP
        (_( GGAACAtatTGTATC_NNP )_) and_CC promoter_NN ARE_VBP (_( AGAACAgcaAGTGCT_NNP )_) of_IN PSA_NNP
        gene_NN [_NN 20_CD ]_NN ,_, respectively_RB ._. Oligo_NNP probes_NNS containing_VBG these_DT
        sequences_NNS also_RB interacted_JJ with_IN AR_NNP protein_NN (_( data_NNS not_RB shown_VBN )_) ._.
        These_DT results_NNS further_JJ suggest_VBP possible_JJ presence_NN of_IN multiple_JJ
        AREs_NNP in_IN the_DT RAR_NNP α_NN gene_NN ._. Functional_NNP importance_NN of_IN multiple_JJ
        AREs_NNP in_IN androgen_NN effects_NNS has_VBZ been_VBN demonstrated_VBN in_IN PSA_NNP gene_NN
        [_NN 20_CD ]_NN ._.
        Stimulation_NNP of_IN RAR_NNP α_NN and_CC γ_NN mRNA_NN in_IN LNCaP_NNP cells_NNS by_IN T_NN
        differed_VBD from_IN that_DT in_IN normal_JJ rat_NN prostate_NN and_CC
        non-tumorigenic_JJ rat_NN prostate_NN epithelial_NN cells_NNS (_( NRP-_NNP 152_CD )_) ,_,
        but_CC was_VBD comparable_JJ to_TO that_DT in_IN tumorigenic_JJ rat_NN prostate_NN
        epithelial_NN cells_NNS (_( NRP-_NNP 154_CD )_) [_NN 13_CD 14_CD ]_NN ._. In_IN cervical_JJ
        carcinoma_NN cells_NNS ,_, the_DT RAR_NNP β_NN gene_NN was_VBD abnormally_RB
        down-regulated_JJ by_IN RA_NNP [_NN 36_CD ]_NN ._. In_IN ER_NNP positive_JJ human_JJ breast_NN
        cancer_NN cells_NNS ,_, RAR_NNP α_NN mRNA_NN was_VBD also_RB up-regulated_JJ by_IN estrogen_NN
        [_NN 16_CD ]_NN ._. Thus_RB ,_, T_NN stimulation_NN of_IN RAR_NNP mRNAs_NNS in_IN LNCaP_NNP cells_NNS
        could_MD be_VB related_VBN to_TO the_DT pathologic_JJ state_NN of_IN the_DT cells_NNS ._.
        LNCaP_NNP cells_NNS contain_VBP high_JJ levels_NNS of_IN functional_JJ AR_NNP with_IN
        mutated_VBN ligand_NN binding_JJ domain_NN and_CC exhibit_NN aberrant_NN cellular_JJ
        responses_NNS to_TO androgen_NN [_NN 5_CD 37_CD 38_CD ]_NN ._. The_DT mutated_VBN AR_NNP when_WRB
        interact_NN with_IN the_DT ARE_VBP of_IN the_DT RAR-α_NNP gene_NN ,_, may_MD trans-activate_JJ
        the_DT gene_NN in_IN an_DT abnormal_JJ fashion_NN resulting_VBG in_IN increases_NNS in_IN
        its_PRP$ mRNA_NN ._.
        In_IN summary_NN ,_, current_JJ results_NNS demonstrate_VBP interactions_NNS
        between_IN T_NN and_CC RA_NNP in_IN the_DT expression_NN of_IN RAR_NNP α_NN and_CC γ_NN and_CC
        EGF-R_NNP ,_, as_RB well_RB as_IN cell_NN growth_NN in_IN LNCaP_NNP cells_NNS ._. These_DT results_NNS
        suggest_VBP that_IN RAR_NNP and_CC EGF-R_NNP signaling_VBG events_NNS might_MD be_VB
        involved_VBN in_IN the_DT effects_NNS of_IN RA_NNP and_CC T_NN on_IN LNCaP_NNP cell_NN growth_NN ._.
        Moreover_RB ,_, EMSA_NNP demonstrated_VBD the_DT presence_NN of_IN putative_JJ ARE_VBP on_IN
        RAR_NNP α_NN promoter_NN ,_, suggesting_VBG that_IN AR_NNP (_( protein_NN )_) -_: DNA_NNP
        interaction_NN might_MD be_VB involved_VBN in_IN the_DT effects_NNS of_IN T_NN on_IN RAR_NNP
        genes_NNS ._. While_IN the_DT importance_NN of_IN these_DT in_IN vitro_NN findings_NNS for_IN
        prostate_NN cell_NN patho-physiology_JJ in_IN vivo_NN must_MD be_VB interpreted_VBN
        with_IN caution_NN ,_, current_JJ results_NNS nevertheless_RB provide_VBP a_DT
        molecular_JJ basis_NN for_IN the_DT interaction_NN between_IN androgen_NN and_CC
        retinoid_NN in_IN LNCaP_NNP cells_NNS ._. Further_RB understanding_VBG the_DT
        down-stream_JJ signaling_VBG events_NNS in_IN such_JJ interaction_NN will_MD
        provide_VB new_JJ insights_NNS into_IN the_DT mechanisms_NNS underlying_VBG normal_JJ
        and_CC pathologic_JJ growth_NN of_IN prostate_NN cells_NNS ,_, and_CC will_MD
        facilitate_VB the_DT use_NN of_IN retinoid_NN analogs_NNS in_IN the_DT prevention_NN or_CC
        treatment_NN of_IN such_JJ diseases_NNS as_IN prostate_NN cancer_NN ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Authors_NNP '_'' contributions_NNS
        Author_NN #_# 1_CD has_VBZ been_VBN responsible_JJ for_IN most_JJS of_IN the_DT
        experiments_NNS including_VBG 3_CD H-_NNP thymidine_NN incorporation_NN ,_, Northern_NNP
        blotting_VBG ,_, electrophoretic_JJ mobility_NN shift_NN assay_NN (_( EMSA_NNP )_) and_CC
        some_DT cell_NN culture_NN experiments_NNS ._. Author_NN #_# 2_CD was_VBD responsible_JJ
        for_IN all_DT EGF-R_NNP experiments_NNS ._. Author_NN #_# 3_CD has_VBZ contributed_VBN
        purified_JJ androgen_NN receptor_NN and_CC its_PRP$ antibody_NN for_IN EMSA_NNP ,_, as_RB
        well_RB as_IN consultation_NN in_IN the_DT design_NN of_IN the_DT experiments_NNS ._.
        Author_NN #_# 4_CD has_VBZ provided_VBN suggestions_NNS for_IN the_DT experiments_NNS and_CC
        potential_JJ clinical_JJ relevance_NN of_IN the_DT findings_NNS ._. Author_NN #_# 5_CD has_VBZ
        been_VBN responsible_JJ for_IN the_DT progress_NN of_IN the_DT experiments_NNS ,_,
        participated_VBD in_IN cell_NN culture_NN experiments_NNS and_CC preparation_NN of_IN
        the_DT manuscript_NN
      
    
  
